loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Solubilizers? Find Solubilizers Agents used in Ruxolitinib to address drug delivery challenges on PharmaCompass.

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    View Presentation

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Ruxolitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 29,201Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 22BASF

    02 2Gangwal Chemicals

    03 1Microlex e.U

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Microlex e.U

    MICROLEX® PVD K30

    arrow
    CPhI India 2024
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Microlex® PVD K30

    Application : Solubilizers

    Excipient Details : It is among the most commonly used solid dispersion carrires to solubilize poorly soluble drugs, It can stabilize amorphous drugs in polymer dispersions and maintain supersaturation of API, aqueous solutions by preventing precipitation/cryst...

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Also Available as Microlex® PVD K90.

    Ingredient(s) : Povidone

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Povidone

    Dosage Form : Tablet

    Category : Solubilizers

    Brand : MICROLEX® PVD K30

    Applications : It is among the most commonly used solid dispersion carrires to solubilize poorly soluble drugs, It can stabilize amorphous drugs in polymer dispersions and maintain supersaturation of API, aqueous solutions by preventing precipitation/crystallization

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Also Available as Microlex® PVD K90.

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Gangwal Chemicals

    KOVIDONE-K

    arrow
    CPhI India 2024
    Not Confirmed

    Gangwal Chemicals

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : KOVIDONE-K

    Application : Coating Systems & Additives, Fillers, Diluents & Binders, Film Formers & Plasticizers, Solubilizers, Thickeners and Stabilizers

    Excipient Details : Kovidone- K series products posses excellent binding, film-forming, dispersing, and thickning properties and are widely used in the following dosage forms. Binder, Solubilizer, Coating agent, Suspending, Stabilizing or viscocity modifying agent

    Pharmacopoeia Ref : USP-NF, EP, BP, IP, JP, FCC

    Technical Specs : PVP K-K-30/ K-17/ K19/ K25/ K90

    Ingredient(s) : Crospovidone, Povidone

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Crospovidone, Povidone

    Dosage Form : Capsule, Tablet

    Category : Coating Systems & Additives, Fillers, Diluents & Binders, Film Formers & Plasticizers, Solubilizers, Thickeners and Stabilizers

    Brand : KOVIDONE-K

    Applications : Kovidone- K series products posses excellent binding, film-forming, dispersing, and thickning properties and are widely used in the following dosage forms. Binder, Solubilizer, Coating agent, Suspending, Stabilizing or viscocity modifying agent

    Pharmacopoeia Ref : USP-NF, EP, BP, IP, JP, FCC

    Technical Specs : PVP K-K-30/ K-17/ K19/ K25/ K90

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    BASF

    KOLLIDON 30

    arrow
    CPhI India 2024
    Not Confirmed

    04

    BASF

    KOLLIDON 90 F

    arrow
    CPhI India 2024
    Not Confirmed

    05

    BASF

    KOLLIDON 17 PF

    arrow
    CPhI India 2024
    Not Confirmed

    06

    BASF

    KOLLIDON 12 PF

    arrow
    CPhI India 2024
    Not Confirmed